Exane BNP Paribas analyst Sami Kassab downgrades Thomson Reuters (NYSE:TRI) from Neutral to Underperform.
Exane BNP Paribas Downgrades Thomson Reuters to Underperform
Exane BNP Paribas analyst Sami Kassab downgrades Thomson Reuters (NYSE:TRI) from Neutral to Underperform.
Related Posts
Viracta Therapeutics To Present Topline Nana-val Results From Stage 1 of the NAVAL-1 Trial At The 2024 Annual Congress Of The Hematology Society Of Taiwan
Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that topline
What’s Going On With Ford Stock Thursday?
Ford shares are trading lower Thursday. The company provided a remeasurement of losses related to pension and other postretirement employee benefits (OPEB).